Sign in
LGNDZ Stock Price, Chart, Stats & News
Ligand Pharmaceuticals, Inc.
Save
Ligand Pharmaceuticals, Inc. (LGNDZ) does not currently pay a dividend.
45,614
Market cap
–
Current P/E
–
Forward P/E
LGNDZ chart
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Ligand Pharmaceuticals, Inc. functions as a biopharmaceutical firm, primarily focusing on developing and acquiring innovative technologies that empower other pharmaceutical companies in their drug discovery and development processes. Its comprehensive product line features treatments such as evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was established in 1987 by Ronald M.
Similar securities
Based on sector and market capitalization
Report issue